Travelogix secure three-year extension with client, and member of the Focus Travel Partnership, Lupus Travel.

 Lupus Travel continues its relationship with data partner of choice, Travelogix, by agreeing on a three-year extension.

We are delighted to announce the signing of a three-year extension to our agreement with independent TMC, and member of the Focus Travel Partnership, Lupus Travel.

Lupus will continue to benefit from our market-leading data management and reporting platform, Analytix. They will also utilise three key modules that sit within the product: DataShare, DataPublisher, and DataValet.

A client since 2018, the extension with Lupus will see us continue our innovative journey together whilst delivering the sort of service responsible for this continued relationship.

Desmond Pluss, Owner of Lupus Travel, said:

“I would like to thank Travelogix for their unwavering support during these past 2 and half years, both commercially, and technologically – via their data management and reporting platform, Analytix.

“It’s great to see them working on innovative new enhancements for the future too, as this has enabled us to be very engaging with our existing clients whilst pushing ahead in securing new business.

“We are delighted to re-sign with our partners at Travelogix and look forward to a bright road ahead.”

Tahir Zia, Director of Sales at Travelogix, said:

“Agreeing on a three-year extension with Desmond Pluss, and the wider team at Lupus is a crucial move as we head into 2023.

“We have been their data partner of choice since 2018, and we’re thrilled to be able to continue this relationship for a further three years.

“We work tirelessly to innovate in line with the needs of our clients and the demands of the travel industry, and long-term relationships such as this one, are a testament to the bonds we build over time with our customers and industry partners alike.

“On behalf of the team here at Travelogix, I can safely say we are delighted with this agreement and look forward to the innovative road ahead with Lupus.”